S-4 - Neoleukin Therapeutics, Inc. (0001404644) (Filer)

1 min to read

S-4 – Neoleukin Therapeutics, Inc. (0001404644) (Filer)

Filed: 2023-08-21 AccNo: 0001193125-23-216091 Size: 18 MB
Source: S-4 – Neoleukin Therapeutics, Inc. (0001404644) (Filer)

Tags: SEC

Weekend Interview: Unispace’s Chely Wright On The Third Rail Of Corporate DEI And Avoiding Death By 1,000 Cuts

This series goes deep with some of the most compelling figures in commercial real estate: the deal-makers, the game-changers, the city-shapers...
Qomolangma Acquisition Shareholders Allow SPAC to Target China-Based Companies

Qomolangma Acquisition in an 8-K said shareholders approved a proposal to permit the SPAC to target companies “to undertake an...
Gamehaus, SPAC Ink $500M Deal Guided By 6 Law Firms – Law360

Gamehaus, SPAC Ink $500M Deal Guided By 6 Law Firms Law360 Source: Gamehaus, SPAC Ink 0M Deal Guided By 6 Law...
Weighty Ambitions

Welcome to The Rundown! Each week we’ll identify and break down for you SPACs that are capturing market share and...
Falcon’s Beyond and FAST Acquisition Corp. II Announce Effectiveness of Form S-4 Registration Statement – Yahoo Finance

Falcon’s Beyond and FAST Acquisition Corp. II Announce Effectiveness of Form S-4 Registration Statement Yahoo Finance Source: Falcon’s Beyond and FAST...